CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. PATENT ANALYSIS.

3.4.1. Patent analysis, by year (2010-2016)
3.4.2. Patent analysis, by region

3.5. REGULATIONS
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Stringent government regulations regarding drug abuse
3.6.1.2. Rise in awareness against drug abuse
3.6.1.3. Surge in funding for drug screening

3.6.2. Restraints

3.6.2.1. Consideration of drug screening as a violation of rights
3.6.2.2. Possible manipulation of drug screening tests

3.6.3. Opportunities

3.6.3.1. Development of novel drug screening tests
3.6.3.2. Tapping the emerging markets

CHAPTER 4 DRUG SCREENING MARKET, BY PRODUCT & SERVICE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EQUIPMENT

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Immunoassay analyzers

4.2.4.1. Market size & forecast

4.2.5. Chromatography instruments

4.2.5.1. Market size and forecast

4.2.6. Breath analyzers

4.2.6.1. Semiconductor breath analyzers
4.2.6.2. Fuel cell analyzers
4.2.6.3. Market size and forecast

4.3. RAPID TESTING DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.3.3.1. Urine testing devices

4.3.3.1.1. Market size and forecast
4.3.3.1.2. Urine testing cups (value and volume estimation)
4.3.3.1.3. U.S.

4.3.3.1.3.1.1. Market size and forecast
4.3.3.1.3.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.4. Canada

4.3.3.1.4.1.1. Market size and forecast
4.3.3.1.4.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.5. UK

4.3.3.1.5.1.1. Market size and forecast
4.3.3.1.5.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.6. Taiwan

4.3.3.1.6.1.1. Market size and forecast
4.3.3.1.6.1.2. Market share analysis by competitors (2012-2016)

4.3.3.1.7. Dip cards
4.3.3.1.8. Cassettes

4.3.3.2. Oral fluid testing devices

4.3.3.2.1. Market size and forecast

4.4. CONSUMABLES

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Assay kits

4.4.4.1. Market size and forecast

4.4.5. Sample collection cups

4.4.5.1. Market size and forecast

4.4.6. Calibrators and controls

4.4.6.1. Market size and forecast

4.4.7. Others

4.4.7.1. Market size and forecast

4.5. LABORATORY SERVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 DRUG SCREENING MARKET, BY SAMPLE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. URINE

5.2.1. Market size and forecast

5.3. ORAL FLUID

5.3.1. Market size and forecast

5.4. BREATH

5.4.1. Market size and forecast

5.5. HAIR

5.5.1. Market size and forecast

5.6. OTHER SAMPLES (BLOOD AND SWEAT)

5.6.1. Market size and forecast

CHAPTER 6 DRUG SCREENING MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. WORKPLACES AND SCHOOLS

6.2.1. Market size and forecast

6.3. CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES

6.3.1. Market size and forecast

6.4. DRUG TESTING LABORATORIES

6.4.1. Market size and forecast

6.5. DRUG TREATMENT CENTERS

6.5.1. Market size and forecast

6.6. HOSPITALS

6.6.1. Market size and forecast

6.7. PERSONAL USERS

6.7.1. Market size and forecast

6.8. PAIN MANAGEMENT CENTERS

6.8.1. Market size and forecast

CHAPTER 7 DRUG SCREENING MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key Market Trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. UK market size and forecast
7.3.3.3. France market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Australia market size and forecast
7.4.3.5. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. ALERE INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. DRAGERWERK AG & CO. KGAA

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance

8.3. ABBOTT LABORATORIES

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. BIO-RAD LABORATORIES, INC.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. DANAHER CORPORATION

8.5.1. Company overview
8.5.2. Company Snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments

8.6. EXPRESS DIAGNOSTICS INTERNATIONAL INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments

8.7. F. HOFFMANN-LA ROCHE AG (ROCHE DIAGNOSTICS)

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. QUEST DIAGNOSTICS INCORPORATED

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. SIEMENS AKTIENGESELLSCHAFT

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. THERMO FISHER SCIENTIFIC INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments